Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,344
Closed -$4.53M 57
2025
Q1
$4.53M Buy
+27,344
New +$4.28M 0.94% 31
2024
Q4
Sell
-22,403
Closed -$3.63M 54
2024
Q3
$3.63M Buy
22,403
+22,391
+186,592% +$3.57M 0.5% 38
2024
Q2
$1.75K Hold
12
﹤0.01% 40
2024
Q1
$1.9K Hold
12
﹤0.01% 36
2023
Q4
$1.88K Sell
12
-119,404
-100% -$18.3M ﹤0.01% 29
2023
Q3
$18.6M Buy
119,416
+1,023
+0.9% +$169K 5.87% 8
2023
Q2
$19.6M Buy
118,393
+63,718
+117% +$10.3M 5.69% 7
2023
Q1
$8.47M Sell
54,675
-7,332
-12% -$1.18M 2.99% 15
2022
Q4
$11M Hold
62,007
4.76% 9
2022
Q3
$10.1M Buy
+62,007
New +$10.5M 4.78% 10

Other funds holding JNJ

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's JNJ Position: Q2 2025 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 27,344 shares — an estimated $4.53M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in JNJ in Q3 2022 and held it in 10 quarters. The position peaked at $19.6M in Q2 2023. 4,087 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 27,344 Johnson & Johnson shares in Q2 2025, an estimated $4.53M.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Johnson & Johnson in Q3 2022 and held it in 10 quarters.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Johnson & Johnson position peaked at $19.6M in Q2 2023.
  • 4,087 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2025, filed 25 Jul 2025.